Senores (SENORES) | Stock Overview & Key Data
Senores Performance Comparison
Stock Range
Today's Range
Low: ₹685.20
High: ₹702.75
on September 30, 2025
52 Week Range
Low: ₹435.25
High: ₹751.20
on January 13, 2025
All-Time High: ₹751.20 on September 9, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR32.9B
EPS
14.68
P/E Ratio (TTM)
48.74
Forward P/E
22.36
P/B Ratio
4.26
PEG Ratio
N/A
Div. Yield
N/A
ROE
7.21%
Beta
N/A
Debt to Equity
38.75
Financial Highlights
Profitability
Gross Margin
52.91%
Operating Margin
20.42%
Profit Margin
14.82%
Returns and Earnings
Return on Assets (TTM)
4.77%
Return on Equity (TTM)
7.21%
EBITDA
INR1.2B
Net Income (TTM)
INR675.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR98.98
Quarterly Revenue Growth (YoY)
71.70%
Quarterly Earnings Growth (YoY)
83.90%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Senores SENORES | 32.95B Small-cap | -4.06% | -1.93% | 18.10% | 22.01% | 20.44% | 20.06% | 20.06% | 20.06% |
| GlaxoSmithKline GLAXO | 458.57B Large-cap | -1.79% | -3.96% | -19.57% | -3.58% | 20.84% | -1.52% | 93.34% | 80.13% |
| Pfizer PFIZER | 231.58B Large-cap | 2.92% | 0.31% | -9.61% | 27.62% | -2.95% | -8.29% | 16.04% | 2.57% |
| Sms Pharmaceuticals SMSPHARMA | 23.10B Small-cap | -7.69% | 9.34% | 3.92% | 17.65% | 0.50% | -29.15% | 185.52% | 181.63% |
| TTK Healthcare TTKHLTCARE | 16.28B Small-cap | -2.66% | 0.24% | -9.50% | -1.96% | -17.55% | -28.09% | 21.98% | 161.51% |
| Kopran KOPRAN | 8.76B Small-cap | -3.91% | 10.93% | -5.79% | -6.24% | -17.43% | -43.97% | 6.92% | 92.78% |
Ownership & Short Interest
Insider Ownership
56.45%
Institutional Ownership
7.77%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
305K
Average 90-Day Volume
283K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SENORES's 52-week high and low?
- In the last 52 weeks, Senores reached a high of ₹751.20 (on N/A) and a low of ₹435.25 (on January 13, 2025).
- What is the market cap and P/E ratio for SENORES?
- Curious about Senores's size and valuation? Its market capitalization stands at 32.95B. When it comes to valuation, the P/E ratio (trailing twelve months) is 48.74, and the forward P/E (looking ahead) is 22.36.
- Does SENORES pay dividends? If so, what's the yield?
- As for dividends, Senores isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Senores's main competitors or similar companies to consider before investing?
When looking at Senores, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO458.57B Healthcare Drug Manufacturers - General -1.52% 93.34% Pfizer
PFIZER231.58B Healthcare Drug Manufacturers - General -8.29% 16.04% Sms Pharmaceuticals
SMSPHARMA23.10B Healthcare Drug Manufacturers - General -29.15% 185.52% TTK Healthcare
TTKHLTCARE16.28B Healthcare Drug Manufacturers - General -28.09% 21.98% Kopran
KOPRAN8.76B Healthcare Drug Manufacturers - General -43.97% 6.92% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Senores Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Senores's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.21%, the Debt to Equity ratio from the most recent quarter is 38.75, and its Gross Profit Margin stands at 52.91%.
- What is the recent revenue and earnings growth for SENORES?
- Looking at Senores's growth, its revenue over the trailing twelve months (TTM) was INR5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 71.70%, and quarterly earnings saw a YoY growth of 83.90%.
- How much of SENORES stock is held by insiders and institutions?
- Wondering who owns Senores stock? Company insiders (like executives and directors) hold about 56.45% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 7.77%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.